Back

Why and how should we use 3D echo in: heart failure?

6 December 2017 (14:22 - 14:45)
Organised by:
Congress Presentation Part of: Clinical use of 3D echo to assess ventricular geometry and function The imaging examination and quality assessment EACVI Premium Access EuroEcho-Imaging 2017

About the speaker

Photo
Doctor Stam Kapetanakis

Guy's and St Thomas' NHS Trust Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Why and how should we use 3D echo in: right heart disease.
Doctor J. Morales Portano (Mexico City, MX)
Slides Video
Presentation thumbnail
Why and how should we use 3D echo in: heart valve diseases?
Professor N. Ajmone Marsan (Leiden, NL)
Slides Video
Presentation thumbnail
Why and how should we use 3D echo in: cancer patients treated with potentially cardiotoxic drugs?
Professor M. Monaghan (London, GB)

Access the full session

Session thumbnail
Clinical use of 3D echo to assess ventricular geometry and function

The Event

Event poster

EuroEcho-Imaging 2017

6 December 2017 14:22 CET
You may be interested in
thumbnail
Congress Presentation
Comparing the prognostic efficacy of 2D and 3D left atrial emptying fraction for the prediction of heart failure in the general population
1 September 2025
thumbnail
Congress Session
Optimizing echocardiographic and CMR assessment in the diagnosis and management of hypertrophic cardiomyopathy
12 May 2023
thumbnail
Congress Presentation
Three-dimensional echocardiography in transcatheter edge-to-edge tricuspid valve repair
27 August 2021
thumbnail
Congress Presentation
Three-dimensional left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar and impact on long-term prognosis
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources